SIRT1 and liver dysplastic nodule: STZ mice developed DN at 24 weeks with upregulated miR‐34a expression in glomeruli, whereas oral administration of MFN reduced miR‐34a levels and upregulated SIRT1 mRNA (Figure 5A,B).